Tech Insider
Economy
Economy
Ozempic box
Ozempic.

Getty Images

  • The US economy could see a surge in growth as more people start to take GLP-1 weight-loss drugs.
  • Goldman Sachs predicted that US GDP could jump by 1% if 60 million Americans took a GLP-1 drug.
  • Goldman Sachs also said that "poor health imposes significant economic costs."

The more people who take GLP-1 weight-loss drugs, the faster the US economy could grow, a Goldman Sachs analyst said in a note last month. 

The US GDP could grow by an extra 1% if 60 million Americans took GLP-1 drugs by 2028, Jan Hatzius, the chief economist at Goldman Sachs, wrote.

Tags
economy, Markets, economy, stock-market, Ozempic, GLP-1, economy-outlook, analyst-note
Source
The more Americans who take Ozempic, the faster the US economy could grow, Gold…